SCHEMBL19021530

SCHEMBL19021530

CC(C)(O)C1CCC(NC(=O)c2cnc3cc(N)c(Cl)cc3c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23731474 1.00 HPGDS (0.67) HPGDS
SCHEMBL18987576 0.91 HPGDS (0.72) HPGDS
SCHEMBL18987575 0.91 HPGDS (0.72) HPGDS
SCHEMBL23731084 0.88 HPGDS (0.68) HPGDS
SCHEMBL18987442 0.88 HPGDS (0.67) HPGDS
SCHEMBL19021410 0.88 HPGDS (0.67) HPGDS
SCHEMBL18987444 0.88 HPGDS (0.67) HPGDS
SCHEMBL18988756 0.88 HPGDS (0.67) HPGDS
SCHEMBL18988758 0.88 HPGDS (0.67) HPGDS
SCHEMBL18987595 0.87 HPGDS (0.66) HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017103851-A1 QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2017-06-22 — — WO disclosed
Send feedback